Efficacy and Safety of Recombinant Human Thrombopoietin (rhTPO) on Coagulation Function and Inflammatory Factors in the Treatment of Patients with Sepsis-Related Thrombocytopenia.

Clin Appl Thromb Hemost · 2025 · PMC11792032 · PMID 39901742

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

approaching significanceP = 0.051so close (0.05 < p ≤ 0.1)

The mortality risk in patients with DIC was 2.123 times higher than in those without DIC, with a P value approaching significance ( P = 0.051).

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.